Dean's Leading by Example Lecture Series
Dr. Jill Kolesar is a member of the Graduate Faculty in the College of Pharmacy, a member of the Markey Cancer Center and holds a joint appointment in Internal Medicine in the College of Medicine.
Jill received her Doctor of Pharmacy degree at the University of Texas Health Science Center in San Antonio, where she also completed a specialty practice residency in oncology/hematology and a fellowship in molecular oncology pharmacotherapy. She received an MS in Epidemiology with an emphasis in Genetic Epidemiology from the University of Wisconsin-Madison, College of Medicine and Public Health in 2016.
Dr. Kolesar contributes substantial and sustained professional service to both the National Cancer Institute (NCI) and several pharmacy organizations. Serving on both the Early Phase and Cancer Prevention Central IRBs (CIRBs), multiple NCI study sections, and the Cancer Therapy and Evaluation Program (CTEP) Pharmacology task force. Jill is a board certified Pharmacotherapy Specialist and an elected fellow of ACCP (American College of Clinical Pharmacy). She has served ACCP as the Chair of the Hematology Oncology PRN, and as a member of the Board of Regents and the Research Institute Board of Trustees. Dr. Kolesar is currently the President of ACCP.
Dr. Kolesar’s research focuses on the drug development of anticancer agents with an emphasis on targeted therapies and biomarkers. She has authored more than 200 abstracts, research articles, and book chapters, and as a principal investigator she has received more than $1.5 million in research funding from the NCI, American Cancer Society and other sources. Jill has received teaching and research awards from local, national and international organizations including the Innovations in Teaching Award from the American Association of Colleges of Pharmacy.